SCHEMBL13800397

SCHEMBL13800397

CCCCOc1ccc(N(Cc2cccc(-c3cc(OC)c(OC)c(OC)c3)c2)C2CCN(Cc3cncc(-c4cc(OC)c(OC)c(OC)c4)c3)CC2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 1/20 0.39
MAOB P27338 1/20 0.39
MEN1 O00255 1/20 0.38
ALDH1A1 P00352 1/20 0.38
CYP2D6 P10635 1/20 0.38
RAB9A P51151 1/20 0.38
KMT2A Q03164 1/20 0.38
TGFBR1 P36897 1/20 0.38
ACVR1 Q04771 1/20 0.38
CCR5 P51681 3/20 0.38
HRH3 Q9Y5N1 1/20 0.37
JAK2 O60674 2/20 0.37
JAK1 P23458 2/20 0.37
BCHE P06276 1/20 0.36
ACHE P22303 1/20 0.36
BACE1 P56817 1/20 0.36
TYK2 P29597 1/20 0.36
JAK3 P52333 1/20 0.36
DRD2 P14416 1/20 0.36
DRD4 P21917 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7223635 0.99 HTR7 (0.39) HTR7MAOBMEN1ALDH1A1CYP2D6
SCHEMBL13800393 0.96 RAB9A (0.41) HTR7MEN1ALDH1A1CYP2D6RAB9A
Hydrochloric Acid SCHEMBL7220176 0.95 RAB9A (0.40) HTR7MEN1ALDH1A1CYP2D6RAB9A
SCHEMBL13800364 0.94 HTR7 (0.40) HTR7MAOBMEN1KMT2ATGFBR1
Hydrochloric Acid SCHEMBL7218967 0.93 HTR7 (0.40) HTR7MAOBMEN1KMT2ATGFBR1
SCHEMBL13800401 0.93 HTR7 (0.46) HTR7MEN1ALDH1A1CYP2D6RAB9A
Hydrochloric Acid SCHEMBL7224495 0.92 HTR7 (0.45) HTR7MEN1ALDH1A1CYP2D6RAB9A
SCHEMBL13800341 0.92 HTR7 (0.43) HTR7MAOBMEN1KMT2ATGFBR1
Hydrochloric Acid SCHEMBL7217713 0.91 HTR7 (0.42) HTR7MAOBMEN1KMT2ATGFBR1
SCHEMBL13800384 0.91 JAK2 (0.37) MEN1ALDH1A1CYP2D6RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090143430-A1 ERYTHROPOIETIN PRODUCTION ACCELERATOR KOWA CO., LTD. (JP) 2009-06-04 US disclosed
US-20090143430-A1 ERYTHROPOIETIN PRODUCTION ACCELERATOR KOWA CO., LTD. (JP) 2009-06-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090143430-A1 ERYTHROPOIETIN PRODUCTION ACCELERATOR EPOR, GHRHR, ARL1 HTR7 3747/4885MAOB 3640/4885MEN1 4312/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.